Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older

Increasing prevalence of infections caused by antimicrobial‐resistant gram‐negative bacteria represents a global health crisis, and while several novel therapies that target various aspects of antimicrobial resistance have been introduced in recent years, few are currently approved for children. Cef...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzese, Richard C., McFadyen, Lynn, Watson, Kenny J., Riccobene, Todd, Carrothers, Timothy J., Vourvahis, Manoli, Chan, Phylinda L.S., Raber, Susan, Bradley, John S., Lovern, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298731/
https://www.ncbi.nlm.nih.gov/pubmed/34687548
http://dx.doi.org/10.1002/cpt.2460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298731/
https://www.ncbi.nlm.nih.gov/pubmed/34687548
http://dx.doi.org/10.1002/cpt.2460

Ejemplares similares